Wells Fargo Raises Globe Life (GL) Target, Keeps Overweight Rating

Globe Life Inc. (NYSE:GL) is one of the Top 10 Stocks Warren Buffett Would Buy in 2026.

Wells Fargo Raises Globe Life (GL) Target, Keeps Overweight Rating

On February 25, 2026, Wells Fargo analyst Elyse Greenspan raised the price target on Globe Life Inc. (NYSE:GL) from $170 to $171 while keeping an Overweight rating on the shares. The firm is lowering earnings estimates for most companies following fourth-quarter guidance that matched or trailed consensus expectations. Wells Fargo is also aligning its valuation models with 2027 earnings and introducing initial estimates for 2028, signaling more extensive coverage in long-term financial forecasting for the sector.

In another event, on February 9, 2026, Globe Life Inc. (NYSE:GL) noted significant insider activity. The company’s Executive Vice President and Chief Strategy Officer, Michael Clay Majors, disclosed a sale of 30,000 shares of the company’s stock. The transaction, valued at $4,406,655, resulted in a -39% change in Michael’s ownership stake in Globe Life Inc. (NYSE:GL).

According to CNN, 69% of 13 analysts covering the stock have assigned a Buy rating as of February 27, 2026, with a 1-year median price target of $171.

Founded in 1900, Globe Life Inc. (NYSE:GL) is a provider of life and supplemental health insurance for middle-income families with headquarters in Texas.

While we acknowledge the risk and potential of GL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GL and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Stocks to Buy in 2026 According to Reddit and 13 High-Quality S&P 500 Financial Stocks According to Hedge Funds.

Disclosure. None. Follow Insider Monkey on Google News.